jueves, 7 de agosto de 2014

VMNI mejora supervivencia en pacientes con EPOC severa estable


The addition of long-term NPPV to standard treatment improves survival of patients with hypercapnic, stable COPD when NPPV is targeted to greatly reduce hypercapnia.
En Lancet Respiratory Medicine



No hay comentarios: